Ligand Reports First Quarter 2025 Financial Results
Go back to Ligand Reports First Quarter 2025 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.05 -0.78 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.83 | 52 Week High | $139.79 | |||
| Open | $288.03 | 52 Week Low | $82.07 | |||
| Day High | $291.82 | P/E | 669.88 | |||
| Day Low | $285.48 | EPS | $0.43 | |||
| Volume | 309,965 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 939,875 | |||||
